US5395620A
(en)
*
|
1989-01-31 |
1995-03-07 |
Coletica |
Biodegradable microcapsules having walls composed of crosslinked atelocollagen and polyholoside
|
IL98087A
(en)
*
|
1990-05-04 |
1996-11-14 |
Perio Prod Ltd |
Preparation for dispensing drugs in the colon
|
US5216130A
(en)
*
|
1990-05-17 |
1993-06-01 |
Albany Medical College |
Complex for in-vivo target localization
|
US5410016A
(en)
*
|
1990-10-15 |
1995-04-25 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5626863A
(en)
*
|
1992-02-28 |
1997-05-06 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5462990A
(en)
*
|
1990-10-15 |
1995-10-31 |
Board Of Regents, The University Of Texas System |
Multifunctional organic polymers
|
WO1996039128A1
(en)
*
|
1995-06-06 |
1996-12-12 |
Hemosphere, Inc. |
Protein particles for therapeutic and diagnostic use
|
US6391343B1
(en)
|
1991-01-15 |
2002-05-21 |
Hemosphere, Inc. |
Fibrinogen-coated particles for therapeutic use
|
SE9101853D0
(sv)
*
|
1991-06-17 |
1991-06-17 |
Jonas Wadstroem |
Improved tissue ashesive
|
CA2117588C
(en)
*
|
1992-02-28 |
1998-08-25 |
Jeffrey A. Hubbell |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5573934A
(en)
*
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
US5419913A
(en)
*
|
1992-03-05 |
1995-05-30 |
Podell; Howard I. |
Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like
|
DE4225730C2
(de)
*
|
1992-08-04 |
2003-04-30 |
Merz Pharma Gmbh & Co Kgaa |
Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung
|
JP3390477B2
(ja)
*
|
1993-01-25 |
2003-03-24 |
生化学工業株式会社 |
薬剤組成物及びその製造法
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
SE518597C2
(sv)
*
|
1994-05-04 |
2002-10-29 |
Medicarb Ab |
Användning av kitosan i kombination med en sulfaterad, negativt laddad polysackarid för framställning av en dentalt verksam munhygienkomposition för behandling av parodontit, plaques och/eller karies
|
DE4416927C1
(de)
*
|
1994-05-13 |
1995-08-31 |
Lohmann Therapie Syst Lts |
Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
|
US5783214A
(en)
*
|
1994-06-13 |
1998-07-21 |
Buford Biomedical, Inc. |
Bio-erodible matrix for the controlled release of medicinals
|
US5928667A
(en)
*
|
1994-06-24 |
1999-07-27 |
University Of Maryland |
Drug delivery device and method for employing the same
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
US5562653A
(en)
*
|
1994-11-16 |
1996-10-08 |
Hercules Incorporated |
Medical devices composed of low ceiling temperature polymers
|
JP3145409B2
(ja)
*
|
1995-03-24 |
2001-03-12 |
フォーカル, インコーポレイテッド |
活性酸素阻害剤の制御送達を用いる癒着の低減
|
US5677284A
(en)
*
|
1995-06-06 |
1997-10-14 |
Regen Biologics, Inc. |
Charged collagen particle-based delivery matrix
|
US5840332A
(en)
*
|
1996-01-18 |
1998-11-24 |
Perio Products Ltd. |
Gastrointestinal drug delivery system
|
US5861174A
(en)
|
1996-07-12 |
1999-01-19 |
University Technology Corporation |
Temperature sensitive gel for sustained delivery of protein drugs
|
US7871637B2
(en)
|
1996-08-27 |
2011-01-18 |
Baxter International Inc. |
Dry hemostatic compositions and methods for their preparation
|
US8303981B2
(en)
|
1996-08-27 |
2012-11-06 |
Baxter International Inc. |
Fragmented polymeric compositions and methods for their use
|
US6066325A
(en)
|
1996-08-27 |
2000-05-23 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
US6706690B2
(en)
|
1999-06-10 |
2004-03-16 |
Baxter Healthcare Corporation |
Hemoactive compositions and methods for their manufacture and use
|
US8603511B2
(en)
|
1996-08-27 |
2013-12-10 |
Baxter International, Inc. |
Fragmented polymeric compositions and methods for their use
|
US7435425B2
(en)
*
|
2001-07-17 |
2008-10-14 |
Baxter International, Inc. |
Dry hemostatic compositions and methods for their preparation
|
US7320962B2
(en)
|
1996-08-27 |
2008-01-22 |
Baxter International Inc. |
Hemoactive compositions and methods for their manufacture and use
|
US7009034B2
(en)
*
|
1996-09-23 |
2006-03-07 |
Incept, Llc |
Biocompatible crosslinked polymers
|
US6566406B1
(en)
*
|
1998-12-04 |
2003-05-20 |
Incept, Llc |
Biocompatible crosslinked polymers
|
US8003705B2
(en)
*
|
1996-09-23 |
2011-08-23 |
Incept Llc |
Biocompatible hydrogels made with small molecule precursors
|
US20090324721A1
(en)
|
1996-09-23 |
2009-12-31 |
Jack Kennedy |
Hydrogels Suitable For Use In Polyp Removal
|
US6054421A
(en)
*
|
1997-09-23 |
2000-04-25 |
Scimed Life Systems, Inc. |
Medical emulsion lubricant
|
US6281175B1
(en)
|
1997-09-23 |
2001-08-28 |
Scimed Life Systems, Inc. |
Medical emulsion for lubrication and delivery of drugs
|
US5945457A
(en)
*
|
1997-10-01 |
1999-08-31 |
A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Science |
Process for preparing biologically compatible polymers and their use in medical devices
|
US7022683B1
(en)
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
DE19825621C2
(de)
*
|
1998-06-08 |
2001-05-23 |
Deutsches Krebsforsch |
Protein zur Regulation von Apoptose
|
AU4696699A
(en)
*
|
1998-06-19 |
2000-01-05 |
University Of Utah Research Foundation |
Hydrogels of water soluble polymers crosslinked by protein domains
|
US7179487B1
(en)
|
1998-06-19 |
2007-02-20 |
University Of Utah Research Foundation |
Hydrogels of water soluble polymers crosslinked by protein domains
|
US20020022588A1
(en)
*
|
1998-06-23 |
2002-02-21 |
James Wilkie |
Methods and compositions for sealing tissue leaks
|
AUPP494798A0
(en)
|
1998-07-29 |
1998-08-20 |
Pacific Biolink Pty Limited |
Protective protein formulation
|
US6632457B1
(en)
*
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
US6242042B1
(en)
|
1998-09-14 |
2001-06-05 |
Lrc Products Ltd. |
Aqueous coating composition and method
|
US6299980B1
(en)
|
1998-09-29 |
2001-10-09 |
Medtronic Ave, Inc. |
One step lubricious coating
|
US6379691B1
(en)
|
1998-09-29 |
2002-04-30 |
Medtronic/Ave, Inc. |
Uses for medical devices having a lubricious, nitric oxide-releasing coating
|
ES2243229T3
(es)
*
|
1999-02-03 |
2005-12-01 |
Powderject Res Ltd |
Formulaciones de particulas de hidrogel.
|
NZ513981A
(en)
*
|
1999-03-08 |
2004-02-27 |
Powderject Res Ltd |
Delivery of microparticle formulations using needleless syringe device for sustained-release of bioactive compounds
|
US20020119921A1
(en)
*
|
1999-03-31 |
2002-08-29 |
Michael Streit |
Thrombospondin-2 and uses thereof
|
WO2000064481A1
(en)
*
|
1999-04-22 |
2000-11-02 |
Eidgenössische Technische Hochschule (ETH) |
Controlled release of growth factors from heparin containing matrices
|
ES2207123T3
(es)
*
|
1999-06-14 |
2004-05-16 |
Baxter International Inc. |
Microesferas de liberacion sostenida.
|
US6864224B1
(en)
*
|
1999-09-01 |
2005-03-08 |
Brown University Research Foundation |
Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US6369037B1
(en)
|
1999-10-19 |
2002-04-09 |
Cornell Research Foundation, Inc. |
Controlled release of doxorubicin
|
AU1792601A
(en)
*
|
1999-12-07 |
2001-06-18 |
Amgen, Inc. |
Thermosensitive biodegradable hydrogels based on low molecular weight pluronics
|
US6831155B2
(en)
*
|
1999-12-08 |
2004-12-14 |
President And Fellows Of Harvard College |
Inhibition of p53 degradation
|
US7179483B2
(en)
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
ES2326209T3
(es)
|
2000-10-27 |
2009-10-05 |
Baxter Healthcare S.A. |
Produccion de microesferas.
|
US20040018228A1
(en)
*
|
2000-11-06 |
2004-01-29 |
Afmedica, Inc. |
Compositions and methods for reducing scar tissue formation
|
GB0103620D0
(en)
*
|
2001-02-14 |
2001-03-28 |
Prometic Biosciences Ltd |
Sterile composition and its preparation
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
US6777000B2
(en)
*
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
DE10112825A1
(de)
*
|
2001-03-16 |
2002-10-02 |
Fresenius Kabi De Gmbh |
HESylierung von Wirkstoffen in wässriger Lösung
|
US20050191361A1
(en)
*
|
2001-08-03 |
2005-09-01 |
Powederject Research Ltd. |
Hydrogel particle formation
|
US20030064033A1
(en)
*
|
2001-08-16 |
2003-04-03 |
Brown Larry R. |
Propellant-based microparticle formulations
|
DE10209821A1
(de)
*
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung von Proteinen an ein modifiziertes Polysaccharid
|
DE10209822A1
(de)
*
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
|
JP3867009B2
(ja)
*
|
2002-04-24 |
2007-01-10 |
三菱電機株式会社 |
周波数特性同定方法および駆動制御装置
|
WO2004024776A1
(en)
*
|
2002-09-11 |
2004-03-25 |
Fresenius Kabi Deutschland Gmbh |
Method of producing hydroxyalkyl starch derivatives
|
WO2004083256A1
(en)
*
|
2003-03-21 |
2004-09-30 |
Unilever N.V. |
Polymer composition of proteins, polysaccharides and / or glycerides
|
US8834864B2
(en)
*
|
2003-06-05 |
2014-09-16 |
Baxter International Inc. |
Methods for repairing and regenerating human dura mater
|
US9592258B2
(en)
|
2003-06-27 |
2017-03-14 |
DePuy Synthes Products, Inc. |
Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
|
US8790637B2
(en)
|
2003-06-27 |
2014-07-29 |
DePuy Synthes Products, LLC |
Repair and regeneration of ocular tissue using postpartum-derived cells
|
US9572840B2
(en)
|
2003-06-27 |
2017-02-21 |
DePuy Synthes Products, Inc. |
Regeneration and repair of neural tissue using postpartum-derived cells
|
EP1641913B1
(de)
|
2003-06-27 |
2016-01-06 |
DePuy Synthes Products, Inc. |
Aus der nabelschnur abgeleitete postpartum zellen und deren herstellungsmethoden und verwendung
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
US20080274948A1
(en)
*
|
2003-08-08 |
2008-11-06 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of Hydroxyalkyl Starch and G-Csf
|
EP1653991A2
(de)
*
|
2003-08-08 |
2006-05-10 |
Fresenius Kabi Deutschland GmbH |
Durch oxime als bindungsgruppe verbundene konjugate eines polymers mit einem protein
|
WO2005014655A2
(en)
*
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein
|
WO2005021580A2
(en)
*
|
2003-08-28 |
2005-03-10 |
Arizona Board Of Regents |
Hydrogels for modulating cell migration and matrix deposition
|
TWI417303B
(zh)
*
|
2004-03-11 |
2013-12-01 |
Fresenius Kabi De Gmbh |
經由還原胺化作用製得之羥烷基澱粉及蛋白質的接合物
|
CN102302787A
(zh)
*
|
2004-03-11 |
2012-01-04 |
费森尤斯卡比德国有限公司 |
羟烷基淀粉和蛋白质的接合物
|
US20060069009A1
(en)
*
|
2004-09-28 |
2006-03-30 |
Messina Darin J |
Treatment of neurological deficits in the striatum or substanta nigra pars compacta
|
CA2588147A1
(en)
*
|
2004-12-08 |
2006-06-15 |
Unilever Plc |
Satiety enhancing food product and a method for manufacturing such
|
EP1848489A2
(de)
*
|
2005-02-16 |
2007-10-31 |
Cytori Therapeutics, Inc. |
Resorbierbare hohle vorrichtungen zur implantation und freisetzung therapeutischer mittel
|
AU2006222187A1
(en)
*
|
2005-03-11 |
2006-09-14 |
Fresenius Kabi Deutschland Gmbh |
Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch
|
US7833979B2
(en)
*
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
WO2007026362A2
(en)
*
|
2005-09-02 |
2007-03-08 |
Colbar Lifescience Ltd. |
Cross-linked polysaccharide and protein matrices and methods for their preparation
|
EP1762250A1
(de)
*
|
2005-09-12 |
2007-03-14 |
Fresenius Kabi Deutschland GmbH |
Konjugate welche durch chemische Ligation zwischen Hydroxyalkylstärken und aktiven Substanzen mit Bildung eines Thiazolidin-Ringes entstehen
|
US8586078B2
(en)
*
|
2005-12-05 |
2013-11-19 |
Rba Pharma Inc. |
Emulsion-containing medical articles
|
PL1971681T3
(pl)
|
2005-12-16 |
2018-01-31 |
Depuy Synthes Products Inc |
Kompozycje oraz sposoby do hamowania niepożądanej odpowiedzi immunologicznej w przypadku transplantacji z brakiem zgodności tkankowej
|
US9125906B2
(en)
|
2005-12-28 |
2015-09-08 |
DePuy Synthes Products, Inc. |
Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
|
CN101454030B
(zh)
*
|
2006-05-31 |
2013-06-26 |
巴克斯特国际公司 |
用于脊柱外科手术中定向细胞向内生长和控制组织再生的方法
|
TWI436793B
(zh)
|
2006-08-02 |
2014-05-11 |
Baxter Int |
快速作用之乾密封膠及其使用和製造方法
|
AU2007343796A1
(en)
*
|
2006-10-25 |
2008-07-24 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
ES2524443T3
(es)
|
2006-11-13 |
2014-12-09 |
DePuy Synthes Products, LLC |
Expansión in vitro de células postparto usando microportadores
|
EP1961411A1
(de)
*
|
2007-02-21 |
2008-08-27 |
FUJIFILM Manufacturing Europe B.V. |
Zusammensetzung mit gesteuerter Freisetzung
|
WO2008153745A2
(en)
|
2007-05-22 |
2008-12-18 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
KR100919603B1
(ko)
*
|
2007-06-13 |
2009-09-29 |
광주과학기술원 |
생체 성장 호르몬의 주사형 서방출 제형 제조용 수화젤을 이용하여 얻어진 주사형 서방출 제형
|
US7985727B1
(en)
|
2007-09-20 |
2011-07-26 |
Abbott Cardiovascular Systems Inc. |
Apo A-I mimetic peptides and methods of treatment
|
US9173890B2
(en)
*
|
2007-09-20 |
2015-11-03 |
Abbott Cardiovascular Systems Inc. |
Sustained release of Apo A-I mimetic peptides and methods of treatment
|
US8101565B2
(en)
*
|
2007-09-20 |
2012-01-24 |
Abbott Cardiovascular Systems Inc. |
Sustained release of Apo A-I mimetic peptides and methods of treatment
|
US7985728B1
(en)
|
2007-09-20 |
2011-07-26 |
Abbott Cardiovascular Systems Inc. |
Sustained release of Apo A-I mimetic peptides and methods of treatment
|
US8044021B2
(en)
*
|
2007-09-20 |
2011-10-25 |
Abbott Cardiovascular Systems Inc. |
Sustained release of apo A-I mimetic peptides and methods of treatment
|
JP2011500237A
(ja)
|
2007-10-30 |
2011-01-06 |
バクスター・インターナショナル・インコーポレイテッド |
内臓または体腔壁の欠陥を治療するための再生性の生体機能性コラーゲン生物基質の使用
|
EP2213282A1
(de)
*
|
2009-01-30 |
2010-08-04 |
Laboratorios Farmaceuticos Rovi, S.A. |
Pharmazeutische Formen zur Freisetzung von Wirkstoffen
|
EP2070950A1
(de)
*
|
2007-12-14 |
2009-06-17 |
Fresenius Kabi Deutschland GmbH |
Hydroxyalkylstärkederivate und deren Herstellungsverfahren
|
EP2070951A1
(de)
*
|
2007-12-14 |
2009-06-17 |
Fresenius Kabi Deutschland GmbH |
Verfahren zur Herstellung eines Hydroxyalkylstärkederivats mit zwei Linkern
|
ITMI20072416A1
(it)
*
|
2007-12-21 |
2009-06-22 |
Sigea Srl |
Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali
|
ES2621610T3
(es)
*
|
2007-12-27 |
2017-07-04 |
DePuy Synthes Products, Inc. |
Tratamiento de la degeneración de discos intervertebrales utilizando células derivadas de tejido cordón umbilical humano
|
WO2009109194A2
(en)
|
2008-02-29 |
2009-09-11 |
Ferrosan A/S |
Device for promotion of hemostasis and/or wound healing
|
KR100971271B1
(ko)
*
|
2008-04-28 |
2010-07-20 |
한양대학교 산학협력단 |
헤파린이 결합된 피브린젤, 그 제조방법 및 키트
|
EP2379087B1
(de)
*
|
2008-12-19 |
2014-08-20 |
DePuy Synthes Products, LLC |
Aus nabelschnurgewebe gewonnene zellen zur behandlung von neuropathischen schmerzen und spastizität
|
US10179900B2
(en)
|
2008-12-19 |
2019-01-15 |
DePuy Synthes Products, Inc. |
Conditioned media and methods of making a conditioned media
|
EP2379089B1
(de)
*
|
2008-12-19 |
2019-04-17 |
DePuy Synthes Products, Inc. |
Regeneration und reparatur von nervengeweben nach einer verletzung
|
US8409606B2
(en)
*
|
2009-02-12 |
2013-04-02 |
Incept, Llc |
Drug delivery through hydrogel plugs
|
US9039783B2
(en)
|
2009-05-18 |
2015-05-26 |
Baxter International, Inc. |
Method for the improvement of mesh implant biocompatibility
|
PT2442835E
(pt)
*
|
2009-06-16 |
2015-03-23 |
Baxter Healthcare Sa |
Esponja hemostática
|
WO2011057131A1
(en)
|
2009-11-09 |
2011-05-12 |
Spotlight Technology Partners Llc |
Polysaccharide based hydrogels
|
AU2010314994B2
(en)
|
2009-11-09 |
2016-10-06 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
JP2013514093A
(ja)
*
|
2009-12-16 |
2013-04-25 |
バクスター・インターナショナル・インコーポレイテッド |
止血スポンジ
|
KR101250543B1
(ko)
*
|
2009-12-28 |
2013-04-03 |
주식회사 삼양바이오팜 |
수화겔, 이의 제조 방법 및 용도
|
SA111320355B1
(ar)
|
2010-04-07 |
2015-01-08 |
Baxter Heathcare S A |
إسفنجة لايقاف النزف
|
JP6289096B2
(ja)
|
2010-06-01 |
2018-03-07 |
バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated |
乾燥した安定な止血組成物を作製するためのプロセス
|
US9084728B2
(en)
|
2010-06-01 |
2015-07-21 |
Baxter International Inc. |
Process for making dry and stable hemostatic compositions
|
CN103037845B
(zh)
|
2010-06-01 |
2015-11-25 |
巴克斯特国际公司 |
用于制备干燥、稳定的止血组合物的方法
|
AP2013007173A0
(en)
|
2011-03-16 |
2013-10-31 |
Amgen Inc |
Potent and selective inhibitors of NAV1.3 and NAV1.7
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
AU2012318257B2
(en)
|
2011-10-11 |
2015-10-01 |
Baxter Healthcare S.A. |
Hemostatic compositions
|
US20130090291A1
(en)
|
2011-10-11 |
2013-04-11 |
Baxter Healthcare S.A. |
Hemostatic compositions
|
US20130108671A1
(en)
|
2011-10-27 |
2013-05-02 |
Baxter Healthcare S.A. |
Hemostatic compositions
|
AU2012347926B2
(en)
|
2011-12-05 |
2018-03-15 |
Incept, Llc |
Medical organogel processes and compositions
|
JP6241624B2
(ja)
|
2012-03-06 |
2017-12-06 |
フェロサン メディカル デバイシーズ エイ/エス |
止血ペーストを収容する加圧容器
|
JP6394916B2
(ja)
|
2012-06-12 |
2018-09-26 |
フェロサン メディカル デバイシーズ エイ/エス |
乾燥止血組成物
|
JP6049901B2
(ja)
*
|
2012-11-27 |
2016-12-21 |
ユタ−イナ ディーディーエス アンド アドバンスト セラピューティクス リサーチ センター |
陰イオン性高分子を含む抗癌剤吸着能力の向上された生分解性マイクロビーズ及びその製造方法
|
TW201446792A
(zh)
|
2013-03-12 |
2014-12-16 |
Amgen Inc |
Nav1.7之強效及選擇性抑制劑
|
AU2014283170B2
(en)
|
2013-06-21 |
2017-11-02 |
Ferrosan Medical Devices A/S |
Vacuum expanded dry composition and syringe for retaining same
|
CN110279885B
(zh)
|
2013-09-19 |
2022-07-26 |
泰尔茂株式会社 |
聚合物颗粒
|
KR102340388B1
(ko)
|
2013-09-19 |
2021-12-17 |
마이크로벤션, 인코포레이티드 |
중합체 필름
|
US9688788B2
(en)
|
2013-11-08 |
2017-06-27 |
Terumo Corporation |
Polymer particles
|
CA2928963C
(en)
|
2013-12-11 |
2020-10-27 |
Ferrosan Medical Devices A/S |
Dry composition comprising an extrusion enhancer
|
KR101614911B1
(ko)
|
2014-05-14 |
2016-04-25 |
재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 |
제 1 및 제 2 생분해성 마이크로 비드를 포함하는 화학색전용 조성물 및 이의 제조방법
|
JP6726852B2
(ja)
|
2014-10-13 |
2020-07-22 |
フェッローサン メディカル ディバイス エー/エス |
止血および創傷治癒に使用するための乾燥組成物
|
JP6747650B2
(ja)
|
2014-12-24 |
2020-08-26 |
フェロサン メディカル デバイシーズ エイ/エス |
第1の物質と第2の物質を保持し混合するためのシリンジ
|
US9907880B2
(en)
|
2015-03-26 |
2018-03-06 |
Microvention, Inc. |
Particles
|
CA2986981A1
(en)
|
2015-07-03 |
2017-01-12 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
EP3518994B1
(de)
|
2016-09-28 |
2024-02-07 |
Terumo Corporation |
Polymerpartikel
|
DE102017207049A1
(de)
*
|
2017-04-26 |
2018-10-31 |
Tetec Tissue Engineering Technologies Ag |
Zellfreie Kombination, hydrogelartiges Material oder Hydrogel sowie Verwendungen davon
|
US11318190B2
(en)
|
2017-05-05 |
2022-05-03 |
United States Government As Represented By The Department Of Veterans Affairs |
Methods and compositions for treating liver disease
|
JP7395113B2
(ja)
|
2018-05-09 |
2023-12-11 |
フェロサン メディカル デバイシーズ エイ/エス |
止血組成物を調製する方法
|
CN114395164B
(zh)
*
|
2022-03-25 |
2022-07-01 |
北京征服者科技有限公司 |
一种多糖复合凝胶及其制备方法和应用
|